These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 14684267)
1. An overview of current delivery systems in cancer gene therapy. El-Aneed A J Control Release; 2004 Jan; 94(1):1-14. PubMed ID: 14684267 [TBL] [Abstract][Full Text] [Related]
2. Cationic lipid vectors for plasmid DNA delivery. Hirko A; Tang F; Hughes JA Curr Med Chem; 2003 Jul; 10(14):1185-93. PubMed ID: 12678793 [TBL] [Abstract][Full Text] [Related]
3. Viral-mediated gene transfer for cancer treatment. Wilson DR Curr Pharm Biotechnol; 2002 Jun; 3(2):151-64. PubMed ID: 12022258 [TBL] [Abstract][Full Text] [Related]
5. In vivo characteristics of cationic liposomes as delivery vectors for gene therapy. Audouy SA; de Leij LF; Hoekstra D; Molema G Pharm Res; 2002 Nov; 19(11):1599-605. PubMed ID: 12458664 [TBL] [Abstract][Full Text] [Related]
6. Cationic liposomes for gene delivery: from biophysics to biological applications. Pedroso de Lima MC; Neves S; Filipe A; Düzgüneş N; Simões S Curr Med Chem; 2003 Jul; 10(14):1221-31. PubMed ID: 12678796 [TBL] [Abstract][Full Text] [Related]
7. Aerosol gene delivery using viral vectors and cationic carriers for in vivo lung cancer therapy. Hong SH; Park SJ; Lee S; Cho CS; Cho MH Expert Opin Drug Deliv; 2015 Jun; 12(6):977-91. PubMed ID: 25423167 [TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel diolein-based LPDII vector for gene delivery. Guo W; Gosselin MA; Lee RJ J Control Release; 2002 Sep; 83(1):121-32. PubMed ID: 12220844 [TBL] [Abstract][Full Text] [Related]
10. Influence of physicochemical properties on pharmacokinetics of non-viral vectors for gene delivery. Takakura Y; Nishikawa M; Yamashita F; Hashida M J Drug Target; 2002 Mar; 10(2):99-104. PubMed ID: 12074546 [TBL] [Abstract][Full Text] [Related]
11. Bioinspired Star-Shaped Poly(l-lysine) Polypeptides: Efficient Polymeric Nanocarriers for the Delivery of DNA to Mesenchymal Stem Cells. Walsh DP; Murphy RD; Panarella A; Raftery RM; Cavanagh B; Simpson JC; O'Brien FJ; Heise A; Cryan SA Mol Pharm; 2018 May; 15(5):1878-1891. PubMed ID: 29590755 [TBL] [Abstract][Full Text] [Related]
12. Current status of non-viral gene therapy for CNS disorders. Jayant RD; Sosa D; Kaushik A; Atluri V; Vashist A; Tomitaka A; Nair M Expert Opin Drug Deliv; 2016 Oct; 13(10):1433-45. PubMed ID: 27249310 [TBL] [Abstract][Full Text] [Related]
13. Non-viral vectors in cancer gene therapy: principles and progress. Schatzlein AG Anticancer Drugs; 2001 Apr; 12(4):275-304. PubMed ID: 11335785 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of multicomponent non-viral vectors for liver directed gene delivery. Wu CH; Sapozhnikov E; Wu GY J Drug Target; 2002 Mar; 10(2):105-11. PubMed ID: 12074537 [TBL] [Abstract][Full Text] [Related]
15. Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls. Appaiahgari MB; Vrati S Expert Opin Biol Ther; 2015 Mar; 15(3):337-51. PubMed ID: 25529044 [TBL] [Abstract][Full Text] [Related]
19. Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors. Galanis E; Vile R; Russell SJ Crit Rev Oncol Hematol; 2001 Jun; 38(3):177-92. PubMed ID: 11369253 [TBL] [Abstract][Full Text] [Related]
20. Cancer gene therapy using adeno-associated virus vectors. Park K; Kim WJ; Cho YH; Lee YI; Lee H; Jeong S; Cho ES; Chang SI; Moon SK; Kang BS; Kim YJ; Cho SH Front Biosci; 2008 Jan; 13():2653-9. PubMed ID: 17981740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]